299 related articles for article (PubMed ID: 9064337)
1. The seven-span transmembrane receptor CD97 has a cellular ligand (CD55, DAF).
Hamann J; Vogel B; van Schijndel GM; van Lier RA
J Exp Med; 1996 Sep; 184(3):1185-9. PubMed ID: 9064337
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the CD55 (DAF)-binding site on the seven-span transmembrane receptor CD97.
Hamann J; Stortelers C; Kiss-Toth E; Vogel B; Eichler W; van Lier RA
Eur J Immunol; 1998 May; 28(5):1701-7. PubMed ID: 9603477
[TBL] [Abstract][Full Text] [Related]
3. Structural characterization of mouse CD97 and study of its specific interaction with the murine decay-accelerating factor (DAF, CD55).
Qian YM; Haino M; Kelly K; Song WC
Immunology; 1999 Oct; 98(2):303-11. PubMed ID: 10540231
[TBL] [Abstract][Full Text] [Related]
4. Molecular cloning and characterization of mouse CD97.
Hamann J; van Zeventer C; Bijl A; Molenaar C; Tesselaar K; van Lier RA
Int Immunol; 2000 Apr; 12(4):439-48. PubMed ID: 10744645
[TBL] [Abstract][Full Text] [Related]
5. Sevenspan transmembrane molecules: novel receptors involved in leukocyte adhesion.
van Lier RA; Eichler W; Hamann J
Immunol Lett; 1996 Dec; 54(2-3):185-7. PubMed ID: 9052875
[TBL] [Abstract][Full Text] [Related]
6. Expression of the EGF-TM7 receptor CD97 and its ligand CD55 (DAF) in multiple sclerosis.
Visser L; de Vos AF; Hamann J; Melief MJ; van Meurs M; van Lier RA; Laman JD; Hintzen RQ
J Neuroimmunol; 2002 Nov; 132(1-2):156-63. PubMed ID: 12417446
[TBL] [Abstract][Full Text] [Related]
7. Structural basis for CD97 recognition of the decay-accelerating factor CD55 suggests mechanosensitive activation of adhesion GPCRs.
Niu M; Xu S; Yang J; Yao D; Li N; Yan J; Zhong G; Song G
J Biol Chem; 2021; 296():100776. PubMed ID: 33992645
[TBL] [Abstract][Full Text] [Related]
8. N-glycosylation of CD97 within the EGF domains is crucial for epitope accessibility in normal and malignant cells as well as CD55 ligand binding.
Wobus M; Vogel B; Schmücking E; Hamann J; Aust G
Int J Cancer; 2004 Dec; 112(5):815-22. PubMed ID: 15386373
[TBL] [Abstract][Full Text] [Related]
9. Expression of CD97 and CD55 in human medullary thyroid carcinomas.
Mustafa T; Klonisch T; Hombach-Klonisch S; Kehlen A; Schmutzler C; Koehrle J; Gimm O; Dralle H; Hoang-Vu C
Int J Oncol; 2004 Feb; 24(2):285-94. PubMed ID: 14719104
[TBL] [Abstract][Full Text] [Related]
10. Expression of the largest CD97 and EMR2 isoforms on leukocytes facilitates a specific interaction with chondroitin sulfate on B cells.
Kwakkenbos MJ; Pouwels W; Matmati M; Stacey M; Lin HH; Gordon S; van Lier RA; Hamann J
J Leukoc Biol; 2005 Jan; 77(1):112-9. PubMed ID: 15498814
[TBL] [Abstract][Full Text] [Related]
11. Tissue distribution of the human CD97 EGF-TM7 receptor.
Jaspars LH; Vos W; Aust G; Van Lier RA; Hamann J
Tissue Antigens; 2001 Apr; 57(4):325-31. PubMed ID: 11380941
[TBL] [Abstract][Full Text] [Related]
12. CD97-decay-accelerating factor interaction is not involved in leukocyte adhesion to endothelial cells.
Boulday G; Hamann J; Soulillou JP; Charreau B
Transplantation; 2002 Feb; 73(3):429-36. PubMed ID: 11884941
[TBL] [Abstract][Full Text] [Related]
13. Molecular analysis of the epidermal growth factor-like short consensus repeat domain-mediated protein-protein interactions: dissection of the CD97-CD55 complex.
Lin HH; Stacey M; Saxby C; Knott V; Chaudhry Y; Evans D; Gordon S; McKnight AJ; Handford P; Lea S
J Biol Chem; 2001 Jun; 276(26):24160-9. PubMed ID: 11297558
[TBL] [Abstract][Full Text] [Related]
14. Expression of the activation antigen CD97 and its ligand CD55 in rheumatoid synovial tissue.
Hamann J; Wishaupt JO; van Lier RA; Smeets TJ; Breedveld FC; Tak PP
Arthritis Rheum; 1999 Apr; 42(4):650-8. PubMed ID: 10211878
[TBL] [Abstract][Full Text] [Related]
15. The expression and action of decay-accelerating factor (CD55) in human malignancies and cancer therapy.
Mikesch JH; Schier K; Roetger A; Simon R; Buerger H; Brandt B
Cell Oncol; 2006; 28(5-6):223-32. PubMed ID: 17167176
[TBL] [Abstract][Full Text] [Related]
16. Structural and functional characterization of a novel T cell receptor co-regulatory protein complex, CD97-CD55.
Abbott RJ; Spendlove I; Roversi P; Fitzgibbon H; Knott V; Teriete P; McDonnell JM; Handford PA; Lea SM
J Biol Chem; 2007 Jul; 282(30):22023-32. PubMed ID: 17449467
[TBL] [Abstract][Full Text] [Related]
17. Role of CD97(stalk) and CD55 as molecular markers for prognosis and therapy of gastric carcinoma patients.
Liu Y; Chen L; Peng SY; Chen ZX; Hoang-Vu C
J Zhejiang Univ Sci B; 2005 Sep; 6(9):913-8. PubMed ID: 16130195
[TBL] [Abstract][Full Text] [Related]
18. Interactions of CD55 with non-complement ligands.
Lea S
Biochem Soc Trans; 2002 Nov; 30(Pt 6):1014-9. PubMed ID: 12440964
[TBL] [Abstract][Full Text] [Related]
19. Shear stress-dependent downregulation of the adhesion-G protein-coupled receptor CD97 on circulating leukocytes upon contact with its ligand CD55.
Karpus ON; Veninga H; Hoek RM; Flierman D; van Buul JD; Vandenakker CC; vanBavel E; Medof ME; van Lier RA; Reedquist KA; Hamann J
J Immunol; 2013 Apr; 190(7):3740-8. PubMed ID: 23447688
[TBL] [Abstract][Full Text] [Related]
20. Human EMR2, a novel EGF-TM7 molecule on chromosome 19p13.1, is closely related to CD97.
Lin HH; Stacey M; Hamann J; Gordon S; McKnight AJ
Genomics; 2000 Jul; 67(2):188-200. PubMed ID: 10903844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
